Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic and metformin are both prescribed for weight loss, but they work through distinct biological pathways. Metformin primarily improves insulin sensitivity and glucose control, while Ozempic (semaglutide) activates GLP-1 receptors to reduce appetite and food intake. Choosing between them depends on your metabolic profile, weight loss goals, and underlying health conditions.

How Metformin Works for Weight Loss

Metformin is a first-line diabetes medication that influences weight loss indirectly. The drug reduces glucose production in the liver, lowers blood sugar, and improves how your cells use insulin. This metabolic shift can decrease appetite in some patients, though weight loss is typically modest—averaging 2–3 pounds over several months.

Metformin does not directly act on hunger centers in the brain. Instead, it modifies gut hormone levels and reduces calorie absorption, making it a gentler option for those with prediabetes or type 2 diabetes. Many people tolerate metformin well, though gastrointestinal side effects like nausea and diarrhea are common, especially at higher doses.

How Ozempic (Semaglutide) Works for Weight Loss

Ozempic activates GLP-1 receptors throughout the body, triggering rapid and significant appetite suppression. Semaglutide slows gastric emptying—the rate at which food moves from your stomach to your intestines—creating prolonged fullness after eating. Clinical trials show average weight loss of 15–22% of baseline body weight over 68 weeks, compared to 2–3% with metformin.

Unlike metformin, semaglutide directly targets the brain's hunger centers and also improves blood sugar control. This dual action makes it effective for both weight management and type 2 diabetes. The appetite-suppressing effect is pronounced, reducing calorie intake without requiring strict dieting or willpower-dependent restriction.

Clinical Evidence: Weight Loss Outcomes

Metformin-based weight loss studies demonstrate modest reductions in body weight, particularly in people with insulin resistance or metabolic syndrome. The Diabetes Prevention Program (DPP) showed metformin reduced progression to type 2 diabetes by 31%, with an average weight loss of 5.6 pounds over 3 years. These results are meaningful for disease prevention but fall short for substantial body recomposition.

Semaglutide clinical trials reveal substantially greater weight loss. The STEP trials enrolled over 4,500 adults with obesity and showed 15–22% body weight reduction, with many participants achieving 20%+ weight loss. PlexusDx compounded semaglutide provides access to the same active pharmaceutical ingredient at a lower cost than branded Ozempic, making evidence-based GLP-1 therapy more affordable.

Cost and Access: PlexusDx vs. Traditional Options

Metformin is inexpensive and widely available through insurance or as a generic—often costing $10–50 monthly. However, branded Ozempic can exceed $900–1,400 per month even with insurance, and many plans restrict coverage for weight loss alone. PlexusDx offers compounded semaglutide injection starting at $149 monthly from licensed 503A pharmacies, requiring no insurance and no membership fee.

PlexusDx serves all 50 states with HSA and FSA eligibility, making GLP-1 therapy financially accessible. For patients considering long-term weight management, the cost-to-benefit ratio favors semaglutide over metformin, especially when priced through PlexusDx's tiered membership models. Precision Peptide Genetic Testing ($99 add-on) can further personalize your therapy by mapping genetic variants in GLP1R, GIPR, FTO, and MC4R pathways.

Which Is Better for Your Weight Loss Goals?

If you have prediabetes or early-stage type 2 diabetes and prefer a gentle, low-cost first step, metformin is reasonable. It carries minimal risk, improves insulin sensitivity, and may prevent diabetes progression. However, metformin alone rarely produces the 15%+ weight loss needed for meaningful health improvements in obesity.

If you have significant weight to lose, semaglutide delivers superior results across clinical studies and real-world practice. Many patients find that appetite suppression removes the psychological burden of constant food cravings, making sustained weight loss achievable. PlexusDx compounded semaglutide provides medical-grade efficacy at accessible pricing, with optional genetic testing to optimize your peptide protocol and predict your individual response.

Combining Metformin and Semaglutide

Many patients benefit from using both medications together. Metformin improves insulin sensitivity and supports cardiovascular health, while semaglutide drives appetite suppression and rapid weight loss. This combination targets multiple metabolic pathways, potentially yielding superior outcomes than either drug alone, particularly in people with insulin resistance or prediabetes.

Your PlexusDx physician can assess whether metformin continuation alongside compounded semaglutide aligns with your metabolic goals and current medications. The combination is safe, well-tolerated, and supported by emerging clinical evidence. A Precision Peptide Genetic Test can reveal your personalized peptide sensitivities, helping your doctor optimize the combination for your genetic makeup.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does metformin cause as much weight loss as Ozempic?

No. Metformin typically produces 2–3 pounds of weight loss over months, while semaglutide (the active ingredient in Ozempic) achieves 15–22% body weight reduction over 68 weeks. Semaglutide works directly on hunger centers in the brain, whereas metformin's weight loss is indirect and modest.

Can I take metformin and semaglutide together?

Yes. Many patients safely combine both medications to target insulin resistance (metformin) and appetite suppression (semaglutide) simultaneously. Your PlexusDx physician will review your complete medication history and metabolic profile to confirm this combination is appropriate for your situation.

Is PlexusDx semaglutide as effective as Ozempic?

PlexusDx compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic, manufactured in licensed 503A compounding pharmacies. The clinical efficacy is equivalent, but PlexusDx pricing starts at $149 monthly—significantly lower than branded Ozempic's $900+ cost, with no insurance required.

What are the side effects of semaglutide compared to metformin?

Metformin commonly causes nausea, diarrhea, and stomach upset. Semaglutide may cause nausea, vomiting, constipation, and decreased appetite—most resolve within 4–8 weeks as your body adjusts. Semaglutide's side effects are generally mild and temporary, while its weight loss benefits are substantial and sustained.

How can PlexusDx Precision Peptide Genetic Testing improve my results?

The Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways. This reveals genetic predispositions to semaglutide response, helping your PlexusDx physician personalize your dose and protocol—ensuring you achieve optimal weight loss while minimizing side effects.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves